Symptomatic vs. Asymptomatic SARS-CoV-2 Infection Rates in Lung Cancer: Longitudinal Nucleocapsid Antibody Analysis

被引：0

作者：

Rodilla, A. ^{[1
,2
]}

Valanparambil, R. M. ^{[3
,4
]}

Mack, P. C. ^{[1
,2
]}

Hsu, C. -Y. ^{[5
]}

Tavolacci, S. ^{[1
,2
]}

Carreno, J. M. ^{[6
]}

Brody, R. ^{[7
]}

Moore, A. ^{[8
]}

King, J. C. ^{[9
]}

Gomez, J. E. ^{[1
,2
]}

Rohs, N. ^{[1
,2
]}

Rolfo, C. D. ^{[1
,2
]}

Gerber, D. E. ^{[10
,11
]}

Minna, J. D. ^{[10
,11
]}

Bunn, P. A., Jr. ^{[12
]}

Garcia-Sastre, A. ^{[6
,7
,13
,14
,15
]}

Krammer, F. ^{[6
,7
]}

Ramalingam, S. ^{[16
]}

Shyr, Y. ^{[5
]}

Ahmed, R. ^{[3
,4
]}

Hirsch, F. R. ^{[1
,2
,7
]}

机构：

[1] Tisch Canc Inst, Ctr Thorac Oncol, New York, NY USA

[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[3] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA

[4] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA

[5] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA

[6] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA

[7] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA

[8] LUNGev Fdn, Bethesda, MD USA

[9] GO2 Lung Canc, Washington, DC USA

[10] UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dept Internal Med, Dallas, TX USA

[11] UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dept Pharmacol, Dallas, TX USA

[12] Univ Colorado, Dept Internal Med, Canc Ctr, Denver, CO 80202 USA

[13] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA

[14] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA

[15] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[16] Winship Canc Inst, Atlanta, GA USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

SARS-CoV-2; infection; anti-nucleocapsid; serosurvey;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.28-03

引用

页码：S404 / S404

页数：1

共 50 条

[21] Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Garrido, Carolina
Hurst, Jillian H.
Lorang, Cynthia G.
Aquino, Jhoanna N.
Rodriguez, Javier
Pfeiffer, Trevor S.
Singh, Tulika
Semmes, Eleanor C.
Lugo, Debra J.
Rotta, Alexandre T.
Turner, Nicholas A.
Burke, Thomas W.
McClain, Micah T.
Petzold, Elizabeth A.
Permar, Sallie R.
Moody, M. Anthony
Woods, Christopher W.
Kelly, Matthew S.
Fouda, Genevieve G.
JCI INSIGHT, 2021, 6 (17)
[22] Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
Kong, Qi
Xiang, Zhiguang
Wu, Yue
Gu, Yu
Guo, Jianguo
Geng, Fei
MOLECULAR CANCER, 2020, 19 (01)
[23] Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
Qi Kong
Zhiguang Xiang
Yue Wu
Yu Gu
Jianguo Guo
Fei Geng
Molecular Cancer, 19
[24] Nucleocapsid Antibody Versus Spike Protein Antibody: a Summative Analysis for Diagnosis of SARS-CoV-2 Infection at any Time
Tin, Sim Sai
Wiwanitkit, Viroj
CLINICAL LABORATORY, 2022, 68 (03) : 667 - 668
[25] Asymptomatic cases with SARS-CoV-2 infection
Wang, Yishan
Kang, Hanyujie
Liu, Xuefeng
Tong, Zhaohui
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1401 - 1403
[26] Prevalence of Asymptomatic SARS-CoV-2 Infection
Han, Dongsheng
Li, Jinming
ANNALS OF INTERNAL MEDICINE, 2021, 174 (02) : 284 - 284
[27] Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection
Yang, Jingyi
Zhang, Ejuan
Zhong, Maohua
Yang, Qingyu
Hong, Ke
Shu, Ting
Zhou, Dihan
Xiang, Jie
Xia, Jianbo
Zhou, Xi
Zhang, Dingyu
Huang, Chaolin
Shang, You
Yan, Huimin
VIROLOGICA SINICA, 2020, 35 (06) : 838 - 841
[28] Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection
Jingyi Yang
Ejuan Zhang
Maohua Zhong
Qingyu Yang
Ke Hong
Ting Shu
Dihan Zhou
Jie Xiang
Jianbo Xia
Xi Zhou
Dingyu Zhang
Chaolin Huang
You Shang
Huimin Yan
Virologica Sinica, 2020, 35 (06) : 838 - 841
[29] Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection
Sui, Zhiwei
Dai, Xinhua
Lu, Qingbin
Zhang, Yulan
Huang, Min
Li, Shufen
Peng, Tao
Xie, Jie
Zhang, Yongzhuo
Wu, Chunchen
Xia, Jianbo
Dong, Lianhua
Yang, Jiayi
Huang, Wenfeng
Liu, Siyuan
Wang, Ziquan
Li, Ke
Yang, Qingfang
Zhou, Xi
Wu, Ying
Liu, Wei
Fang, Xiang
Peng, Ke
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
[30] Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody
Terry, James S.
Anderson, Loran BR.
Scherman, Michael S.
McAlister, Carley E.
Perera, Rushika
Schountz, Tony
Geiss, Brian J.
VIROLOGY, 2021, 558 : 28 - 37

← 1 2 3 4 5 →